On September 24, 2021, at the initiative of the Kingdom of Thailand, the Charge d’affaires of the Embassy of the Kingdom of Thailand, Mr. Paradorn Rangsimaporn visited the biopharmaceutical plant «OtarBioPharm».
During the visit, Mr. Paradorn Rangsimaporn got acquainted with the history and activities of the Institute with interest, and also asked about the production of the QazVac vaccine and its distinctive features from the world analogues «Sputnik V», «Hayat-Vax», «Pfizer», «Sinovac-CoronaVac» and «AstraZeneca».
The management of the Institute told about the development of four more anti-coronavirus vaccines (subunit, two vector vaccines based on influenza and capripoxvirus viruses, a live vaccine) being developed as part of the scientific and technical program «Development of COVID-19 coronavirus infection vaccine» for 2020-2022.
The guest of honor examined the products of our Institute with special interest and received information about the purpose and composition of each biological drug produced by the Institute. The meeting discussed the possibility of purchasing vaccines produced by the Institute, as well as their safety, effectiveness and quality.
During the visit, Mr. Paradorn Rangsimaporn expressed a desire to cooperate with our Institute.
At the end of the meeting with the guest of honor, the parties agreed to maintain regular working contacts within the framework of joint discussion of issues on biological safety.
